Upperton Limited, founded in 1999, is a privately owned biotech company based in Nottingham, UK and specialising in the development of novel micro and nanoparticles for the pharmaceutical and other industries. Its core technologies include specialised spray drying processes that can be applied to customers' products to enhance their delivery and performance. The Company has recently co-patented rP-nano™ technology with Novozymes as a next generation technology for producing nano-sized particles from proteins, with broad application. The rP-nano™ technology offers unique competitive advantages over current methods of producing nanoparticles. Upperton welcomes academic and industrial partners to explore and commercialise this technology.